🇺🇸 FDA
Patent

US 6162800

N-(pyrimidinyl)-aspartic acid analogs as interleukin-1.beta. converting enzyme inhibitors

expired A61KA61K38/00A61P

Quick answer

US patent 6162800 (N-(pyrimidinyl)-aspartic acid analogs as interleukin-1.beta. converting enzyme inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Dec 19 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/00, A61P, A61P29/00, A61P37/00